Vimarsana
Biggest News Aggregation in the World

Between Nov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Between Nov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Between Nov Today - Breaking & Trending Today

Short-term androgen deprivation therapy does not improve survival in patients receiving postoperative radiotherapy for prostate cancer - Vimarsana News

Short-term androgen deprivation therapy does not improve survival in patients receiving postoperative radiotherapy for prostate cancer

1. There was no significant difference in metastasis-free survival between the ADT and non-ADT groups over 10 years. 2. Adverse events were comparable between both groups and no fatalities were reported. Evidence Rating Level: 1 (Excellent) Study Rundown: Short-term androgen deprivation therapy (ADT) with primary adjuvant radiotherapy is known to improve metastasis-free survival in patients

Bombay High Court grants Sameer Wankhede relief in Sushant Rajput drug case - Vimarsana News

Bombay High Court grants Sameer Wankhede relief in Sushant Rajput drug case

Between Nov 2023 & Mar 2024, Sameer Wankhede got eight notices from the NCB regarding Sushant Singh Rajput drug case that he challenged in Bombay HC

#VisualAbstract: Methotrexate alleviates pain among patients with hand osteoarthritis and concurrent synovitis - Vimarsana News

#VisualAbstract: Methotrexate alleviates pain among patients with hand osteoarthritis and concurrent synovitis

1. Methotrexate 20 mg once weekly resulted in significant pain reduction among patients with hand osteoarthritis of the inflammatory phenotype. 2. Adverse events in the treatment group were comparable to the placebo group. Evidence Rating Level: 1 (Excellent) Study Rundown: Hand osteoarthritis is a debilitating condition with limited treatment options. Topical therapy, oral analgesics, and non-pharmacological therapy

Methotrexate alleviates pain among patients with hand osteoarthritis and concurrent synovitis - Vimarsana News

Methotrexate alleviates pain among patients with hand osteoarthritis and concurrent synovitis

1. Methotrexate 20 mg once weekly resulted in significant pain reduction among patients with hand osteoarthritis of the inflammatory phenotype. 2. Adverse events in the treatment group were comparable to the placebo group. Evidence Rating Level: 1 (Excellent) Study Rundown: Hand osteoarthritis is a debilitating condition with limited treatment options. Topical therapy, oral analgesics, and

Ferric carboxymaltose comparable to oral iron supplementation for pregnant women with anemia - Vimarsana News

Ferric carboxymaltose comparable to oral iron supplementation for pregnant women with anemia

1. Although anemia prevalence at 36 weeks was slightly lower in the ferric carboxymaltose group compared to standard-of-care, statistical significance was not achieved. 2. Adverse events between both groups were comparable; there were no changes in birth weight. Evidence Rating Level: 1 (Excellent) Study Rundown: Anemia affects more than one-third of all pregnancies in Africa.